Our Evidence – mPATH

mPATH™ Doubles Colorectal Cancer Screening Rates

In a large randomized controlled trial funded by the National Cancer Institute, mPATH™ doubled the number of patients who completed screening for colorectal cancer. Patients in this study faced significant barriers to care: one-third had limited literacy and half had annual incomes below $20,000. Despite these barriers, mPATH™ was able to double cancer screening and found over twice as many patients with pre-cancerous polyps.

Reference: Miller DP et al. Effect of a Digital Health Intervention on Receipt of Colorectal Cancer Screening in Vulnerable Patients. Annals of Internal Medicine 2018.

mPATH™ Doubles Colorectal Cancer Screening Rates

Reference: Miller DP et al. Effect of a Digital Health Intervention on Receipt of Colorectal Cancer Screening in Vulnerable Patients. Annals of Internal Medicine 2018.

40% of Invited Patients Visit mPATH™. Almost Everyone Completes It

We sent a patient portal (MyChart) outreach message to 1000 randomly selected patients who may be overdue for lung cancer screening. Over 400 patients visited mPATH™ in response, and 86% of all visitors completed the program.

Reference: Dharod A et al. The Reach and Feasibility of an Interactive Lung Cancer Screening Decision Aid Delivered by Patient Portal. Applied Clinical Informatics 2019

Electronic Health Record Data Misses Two-Thirds Of Patients Who Need Lung Cancer Screening. mPATH™ Finds Them All.

Whether or not a patient needs lung cancer screening depends on their age, how much they have smoked, and when (if ever) they quit smoking. In one of our pilot studies, mPATH™ found over 330 patients who needed lung cancer screening. Of these patients, the Electronic Health Record only identified 35% of them as needing screening. Relying on the Electronic Health Record alone would miss two-thirds of people who could benefit from this life saving test.

Reference: Patel N et al. A Comparison of Smoking History in the Electronic Health Record with Self-Report. American Journal of Preventive Medicine 2020.

Electronic Health Record Data Misses Two-Thirds Of Patients Who Need Lung Cancer Screening. mPATH™ Finds Them All.

Reference: Patel N et al. A Comparison of Smoking History in the Electronic Health Record with Self-Report. American Journal of Preventive Medicine 2020.

mPATH™ Detects Over Twice As Many Patients With Depression, Fall Risk, Or Intimate Partner Violence.

In a study involving 23,000 patients in six different primary care clinics, mPATH™ identified over twice as many patients with concerns that could warrant immediate clinical action. Compared to usual screening by nursing staff, mPATH™ identified over twice as many patients with depression (4% vs. 1.5%), fall risk (16% vs 6%), or intimate partner violence (3% vs 0.1%). We are proud that mPATH™ finds those who may need help.

Reference: Miller DP et al. Universal Screening in Primary Care Practices by Self-administered Tablet vs Nursing Staff. JAMA Network Open 2022.